Literature DB >> 27239131

Loss of heterozygosity and mRNA expression at deleted in colorectal cancer gene locus in gastric cancer.

D X Wang1, D C Fang1, Y H Luo1, W W Liu1.   

Abstract

AIM: To assess the effects of the deleted in colorectal cancer (DCC) gene changes on the development and progression of gastric cancer.
METHODS: The loss of heterozygosity (LOH) and mRNA expression DCC gastric cancer using a PCR-based detection method.
RESULTS: LOH was found in 35.3% (18/51) of the specimens, and the LOH was more frequently detected in tumors from patients with stage III or IV cancer (50.5%) than those in stages I or II (14.3%) (P < 0.05). The occurrence of LOH was not found to correlate with the histological type, tumor size, invasion depth and lymph node metastasis of gastric cancer. The mRNA expression of the DCC gene was studied in 26 of the 51 cases, of which LOE was found in 30.8% (8/26). LOE was not significantly correlated to LOH or other clinicopathological parameters.
CONCLUSION: LOH and LOE of DCC gene are frequently encountered in gastric cancer, and the LOH of DCC gene is a late event associated with progression of gastric cancer.

Entities:  

Keywords:  DCC gene; Gene expression; Heterozygosity loss; Stomach neoplasms; mRNA

Year:  1997        PMID: 27239131      PMCID: PMC4842872          DOI: 10.3748/wjg.v3.i3.156

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

2.  DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18.

Authors:  E Porfiri; L M Secker-Walker; A V Hoffbrand; J F Hancock
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

Review 3.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

4.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

5.  Role of intestinal metaplasia in the histogenesis of gastric carcinoma.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

6.  Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Authors:  R Kikuchi-Yanoshita; M Konishi; H Fukunari; K Tanaka; M Miyaki
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

7.  Loss of heterozygosity of tumor suppressor genes in testis cancer.

Authors:  H Q Peng; D Bailey; D Bronson; P E Goss; D Hogg
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

8.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

Authors:  C S Cropp; R Lidereau; G Campbell; M H Champene; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.

Authors:  H Iino; M Fukayama; Y Maeda; M Koike; T Mori; T Takahashi; R Kikuchi-Yanoshita; M Miyaki; S Mizuno; S Watanabe
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

10.  Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.

Authors:  T Enomoto; M Fujita; C Cheng; R Nakashima; M Ozaki; M Inoue; T Nomura
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.